Vape use among teens dropping for the first time as government regulation stems access
Latest figures from the Generation Vape study reveal 85 per cent of Australian teens aged 14-17 have never vaped, up from 82 per cent in 2023.
The proportion of young people who have never smoked is also at its highest too, at 94 per cent.
It's a promising sign teens are turning away from nicotine products, with chief investigator of the study Professor Becky Freeman saying the 'social acceptability of vaping over the past few years has shifted'.
'Young people tried vaping as it was marketed to them as fun, 'safe' and full of great flavours, but increasingly young people report the realities of vaping addiction and harm to their wellbeing,' Professor Freeman said.
Access to vape products has also declined since the introduction of federal vape laws in July 2024 that aim to limit the sale of vapes to pharmacies only, regardless of nicotine content.
About one in four young people reported purchasing their own vape, down from roughly one in three before the laws came into play.
Tobacconist and vape shops remained a major source of vape sales with about one in three teens buying from such a retailer, highlighting ongoing difficulties with regulation and enforcement.
Chair of the Cancer Council's tobacco issues committee Alecia Brooks said the latest figures were encouraging indicators that vaping laws are protecting young people, but that some retailers 'continue to exploit young people'.
'Some tobacconists and vape shops are still blatantly selling illegal vapes to young people,' Ms Brooks said.
It comes as calls to WA's poisons hotline from concerned parents worried their babies have been exposed to vapes have tripled just six months into the year.
Speaking on the matter in Budget Estimates earlier this month, Health Minister Meredith Hammat said the spike in calls reflected 'a growing awareness in the community about the harmful nature of vapes'.
Since January 2024 the Therapeutic Goods Administration and Australian Border Force have seized more than 10 million illicit vapes with a street value of nearly half a billion dollars.
Federal Health Minister Mark Butler said 'vaping rates for young Australians have now turned the corner'.
'Our education and prevention campaigns as well as support to deter people from taking up vaping and smoking or to quit are making a difference,' he said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
7NEWS
5 hours ago
- 7NEWS
Movement the key to tackling kids' mental health crisis in Australia
A major Australian study has found that regular movement, even unstructured play or casual activity, can significantly reduce symptoms of depression and anxiety in children and teenagers. Researchers at the University of South Australia reviewed 375 clinical trials involving more than 38,000 young people aged between five and 18. Their findings show that physical activity has a powerful impact on mental health, and the benefits can appear within weeks. 'We found that when children and teenagers moved more, through play, sport or exercise, it significantly reduced depression and anxiety,' said lead researcher Dr Ben Singh, a research fellow at UniSA. The research comes amid growing concern about youth mental health, with one in four Australian children now experiencing symptoms of depression or anxiety, often from a young age. Singh said pressures from school, uncertainty about the future, and constant exposure to social media were major contributors. He believes movement is a low-cost, accessible tool that can help families, schools and policymakers respond. 'A lot of children either don't receive treatment or don't respond well to traditional methods like therapy or medication,' he said. 'Movement gives us a practical alternative.' The study found the greatest mental health improvements occurred in programs lasting fewer than 12 weeks, meaning children don't need to wait months to see results. Importantly, the activity didn't need to be intense or structured. Informal movement, such as walking, riding a bike or playing a game outside, delivered similar mental health benefits to team sports or exercise classes. 'It doesn't have to be elite sport,' Singh said. 'A game of backyard cricket or a bike ride with friends is enough. What matters most is that kids are active.' Beyond physical benefits, movement was shown to boost confidence, improve energy levels and support social interaction, particularly when done with peers. 'Children who move more tend to feel better, connect more and build confidence,' Singh said. 'It's something every parent and teacher can encourage.' The research team is now calling on schools, communities and health professionals to treat physical movement as a key part of mental health care. 'Movement should be part of the conversation when we talk about supporting young people,' Singh said. 'It's free, it's effective and it could make a lasting difference.'
Perth Now
7 hours ago
- Perth Now
‘Toxic' claim against supplement giant
Australian supplement giant Blackmores is facing potential class-action lawsuit, over claims that excessive levels of vitamin B6 in some of the company's over-the-counter products have led to serious health complications. Dominic Noonan-O'Keeffe began taking Blackmores supplements in May 2023 to support his health, ahead of the birth of his first child. Unaware the magnesium product contained potentially 'toxic' levels of vitamin B6, he claims he soon developed severe symptoms – including fatigue, headaches, muscle spasms, heart palpitations, and loss of sensation, according to Polaris lawyers. Doctors later diagnosed him with neuropathy linked to excessive B6 intake. Despite stopping in early 2024, Mr Noonan-O'Keeffe claims he continues to suffer daily from nerve pain and other symptoms. Polaris Lawyers – who are representing Mr Noonan-O'Keeffe, the lead plaintiff in the potential class-action – allege they later discovered the magnesium product contained about 29 times the recommended daily intake of vitamin B6. Mr Noonan-O'Keeffe claims he suffered lasting health impacts after taking Blackmores Magnesium+. Supplied Credit: Supplied Polaris Lawyers is now investigating a proposed class action against Blackmores for the excessive B6 levels in their vitamin supplements. 'It's alarming to walk down the vitamin aisle of any chemist in Australia and see vitamin supplements containing levels of B6 which are far and above the recommended daily intake,' Polaris Lawyers Founder and Principal Nick Mann said. 'What happened to Dominic is tragic, but he is not alone – we are aware of reports that excessive levels of B6 in over-the-counter supplements may have caused lasting injuries to hundreds of Australians. 'Polaris Lawyers is currently investigating a class action on behalf of anyone who has suffered injuries as a result of excessive levels of B6 as a result of taking Blackmores vitamin supplements.' Blackmores is one of the country's biggest supplement providers. Supplied Credit: Supplied In an interim decision report released in June, the TGA acknowledged no clear consensus on a safe vitamin B6 level that fully prevents peripheral neuropathy. The decision proposed rescheduling products containing over 50mg per day as 'Pharmacist Only Medicines.' A Blackmores spokesperson said they were aware of the TGA's proposed changes. 'At Blackmores, we are committed to the highest standards of product quality and consumer safety. All our products, including those containing Vitamin B6, are developed in strict accordance with the regulatory requirements of the Therapeutic Goods Administration (TGA),' the spokesperson said. 'This includes compliance with maximum permitted daily doses and the inclusion of mandated warning statements. 'We acknowledge the interim decision issued by the TGA and we will ensure full compliance with its final determination.'
7NEWS
11 hours ago
- 7NEWS
Class action looms over Blackmores after vitamin B6 toxicity causes ‘tragic' injuries to expecting father
A young father left with devastating injuries is at the centre of a looming class action against a popular Australian health supplement company. Dominic Noonan-O'Keeffe says he was taking multiple over-the-counter Blackmores supplements, to bolster his health before becoming a father. But one magnesium product he was taking contained 29 times the recommended daily intake of vitamin B6 — making it toxic to his body, according to Polaris Lawyers. WATCH THE VIDEO ABOVE: Class action on the cards for popular health supplement company. The Melbourne law firm's founder and principal Nick Mann said he is aware of hundreds of Australians reporting lasting injuries from B6 consumed through over-the-counter supplements. While B6 is an essential vitamin for the brain, nervous system, immune system, hormonal regulation and metabolism, and can be found naturally in food — too much is toxic. It can leave those who consume unsafe amounts with nerve damage, migraines, heart spasms, and sensations of burning or numbness across the body. For Noonan-O'Keeffe, 'significant fatigue, excruciating headaches and hypersensitivity to his environment' began in August 2023, three months after he began taking Blackmores supplements. 'His symptoms escalated, with Dominic experiencing muscle spasms, neuralgia, heart palpitations, visual disturbances and loss of sensation across his body,' Polaris Lawyers said. 'Dominic was left unable to concentrate, struggling to sleep, constantly in pain and even at times found it difficult walking. His medical team would go on to identify neuropathy caused by excessive B6 levels in the Blackmores supplements.' Such symptoms of B6 toxicity are widely reported, but the Therapeutic Goods Administration (TGA) said that 'many people are not aware' of them, in a 2022 alert to raise awareness. This alert was published by the TGA one month after it strengthened labelling requirements on products with daily doses that included over 10mg of vitamin B6. Noonan-O'Keeffe wants further changes to the way supplements are sold. In a June interim decision report discussing amendment to the Poisons Standard, the TGA could not find a consensus on the levels of B6 safe enough to totally ensure against the development of peripheral neuropathy. 'Previously, it was generally considered that high intake greater than 200mg per day taken over a long period of time was required to develop peripheral neuropathy,' TGA said. But it cited a European literature review which found supplemental doses of less than 50mg per day had caused peripheral neuropathy in some people, and there were notes of 'large inter-individual differences in sensitivity to vitamin B6 toxicity'. The TGA listed 174 reports of nerve-damage conditions as of June 4, and cited concerns of under-reporting. In its 2022 warning, the TGA said that in many cases of adverse reactions to B6 toxicity, patients 'were unaware they had consumed vitamin B6 as the product they were taking was a magnesium supplement'. Of the 32 cases of peripheral neuropathy under review at the time of the alert, 28 per cent involved 'multiple medicines containing vitamin B6, some of which did not have a label warning because they contained less than 50mg of vitamin B6.' In the class action call-out for anyone who believes they may have suffered injuries as a result of B6 toxicity, Polaris Lawyers described how Noonan-O'Keeffe 'could not have imagined the significant long term medical problems that taking the supplement would cause'. Mann said Noonan-O'Keeffe's case was 'tragic' but noted that he 'is not alone'. ''It's alarming to walk down the vitamin aisle of any chemist in Australia and see vitamin supplements containing levels of B6 which are far and above the recommended daily intake.' The TGA interim decision outlines a rescheduling of vitamin B6, so that products with daily dosages over 50mg will be classified as 'Pharmacist Only Medicines'. A Blackmores spokesperson told 'All our products, including those containing Vitamin B6, are developed in strict accordance with the regulatory requirements of the TGA 'This includes compliance with maximum permitted daily doses and the inclusion of mandated warning statements. We acknowledge the interim decision issued by the TGA, and we will ensure full compliance with its final determination.'
